AbbVie
ABBV
#33
Rank
$259.25 B
Marketcap
$146.60
Share price
-0.78%
Change (1 day)
7.01%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of February 2023 (TTM): 4.48

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.48398. At the end of 2022 the company had a P/S ratio of 4.10.

P/S ratio history for AbbVie from 2012 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20224.10-3.65%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.48-44.78%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1 148.27%๐Ÿ‡บ๐Ÿ‡ธ USA
4.99 11.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.05-9.64%๐Ÿ‡บ๐Ÿ‡ธ USA
3.88-13.41%๐Ÿ‡บ๐Ÿ‡ธ USA
3.24-27.74%๐Ÿ‡บ๐Ÿ‡ธ USA
4.37-2.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.70-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
7.63 70.16%๐Ÿ‡บ๐Ÿ‡ธ USA